ONCOLOGIE Editorial Excellence Award 2022

Dear Colleagues,

We are pleased to announce that the winners of the “2022 ONCOLOGIE Editorial Excellence Award (award for the editorial board member with the best contribution of the year) are Prof. Xavier Troussard, Prof. YiHu, Prof. Haili Qian, Prof. Francesco Cicone, and Dr. Giuseppe E. Umana, Prof. Xiaobin Lv. These Six editorial members for the “2022 ONCOLOGIE Editorial Excellence Award” were selected based on the following criteria:

– The quantity and quality of entries/papers contributed or special issue established;

– Active in the current submission system, including reviewing papers and timely responding to the office editors;

– Different ways of journal promotion in 2022.

Prof. Xavier Troussard

Laboratoire d'hématologie biologique, CHU de Caen Normandie, Caen, France. 

Interest: Hematologic malignancies, particularly chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL); Clinical trials and biology in chronic lymphoproliferative disorders; Organization of healthcare systems

Prof. Yi Hu

State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.

Interest: Nanomedicines; Mitochondria; Macrophage 

Prof. Haili Qian

State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Interest: Molecular Oncology; Cancer biology; Immunotherapy; Tumor metastasis

Prof. Francesco Cicone

Department of Experimental and Clinical Medicine, and Neuroscience Research Centre, PET/RM Unit, “Magna Graecia” University of Catanzaro, Nuclear Medicine Unit, University Hospital “Mater Domini”, Catanzaro, Italy.

Interest: PET/CT cancer diagnostics; Nuclear medicine therapy; Brain tumor imaging

Dr. Giuseppe E. Umana

Department of Neurosurgery, Cannizzaro Hospital, Trauma Center, Gamma Knife Center, Catania, Italy.

Interest: Neuro-oncology; Stereotactic radiosurgery; Skull base; Gliomas; Meningiomas; Schwannomas; Craniovertebral junctions tumors; Spine tumors; Peripheral nerve sheath tumors; Mixed reality and augmented reality

Prof. Xiaobin Lv

Center Lab, the Third Affiliated Hospital of Nanchang University, Nanchang, China

Interest: Post-translational modification, Non-coding RNA, Chemotherapy resistance

Each winner will receive an award certificate and a full APC waiver for one article accepted by the journal that is submitted within 12 months after receiving the award.

Oncologie Editorial would like to congratulate the winners on their accomplishments. We also wish to thank all the Editorial Board Members for their contributions to ONCOLOGIE.